Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of molecular markers on treatment selection in advanced colorectal cancer.

European journal of cancer (Oxford, England : 1990) - 1 Sept 2009

Prenen Hans, Tejpar Sabine, Van Cutsem Eric

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiogenesis Inhibitors
Share to Antibodies, Monoclonal
Share to Antineoplastic Combined Chemotherapy Protocols
Share to Neoplastic Cells, Circulating

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Proto-Oncogene Proteins p21(ras)

Share to Randomized Controlled Trials as Topic

Share to ras Proteins

Share to Receptors, Fc

Source

Identifiers

PMID: 19775606
DOI: 10.1016/S0959-8049(09)70018-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of molecular markers on treatment selection in advanced colorectal cancer.PMID 19775606Read ↗

Molecular predictors of prognosis and response to therapy in colorectal cancer.Semantic proximity Read ↗

Molecular markers in colorectal cancer.Semantic proximity Read ↗

Biomarker-based prediction of response to therapy for colorectal cancer: current perspective.Semantic proximity Read ↗

Evolving molecular classification by genomic and proteomic biomarkers in colorectal cancer: Potential implications for the surgical oncologistSemantic proximity Read ↗

Clinical relevance of colorectal cancer molecular subtypesSemantic proximity Read ↗

Predictive and prognostic markers in the treatment of metastatic colorectal cancer (mCRC): personalized medicine at work.Semantic proximity Read ↗

Prognostic and Predictive Biomarkers in Colorectal Cancer: Implications for the Clinical Surgeon.Semantic proximity Read ↗

Molecular biomarkers of resistance to anti-EGFR treatment in metastatic colorectal cancer, from classical to innovationSemantic proximity Read ↗

Genetic prognostic and predictive markers in colorectal cancer.Semantic proximity Read ↗

Predictive Biomarkers in Colorectal Cancer: From the Single Therapeutic Target to a Plethora of Options.Semantic proximity Read ↗

Predictive and Prognostic Markers in Colorectal CancerSemantic proximity Read ↗

Molecular Markers Beyond Microsatellite Instability for Assessing Prognosis in Early-Stage Colorectal Cancer: What Happens at Relapse?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.